Forside

NCGC presents their recommendation to the Minister of Health

...
READ MORE

The NCGC prostate cancer study is published in European Urology

  The study by Løvf et al, “High degree of genomic heterogeneity in multifocal primary prostate cancer” is now in press in European Urology (Journal impact factor 17,6). This detailed study by the group of Rolf I Skotheim at the OUS Institute for...

NCGC publishes project report

After completion of our first two national projects, completing the exomes of tumours and normal tissue from more than 1000 patients, we have made a printed report, regrettably only in Norwegian. The report consists of an introduction to cancer genomics and...

What is personalised cancer treatment?

  Personalised medicine, or precision medicine, is when we can better adapt disease treatment to the genetics of each patient and molecular subtype of the disease The recent development of high-throughput DNA sequencing hs enabled us to analyse in molecular...